Active Pharmaceutical Ingredientia
Progestogen et estrogen | |||
Product Name | Specificatio | Probatus | Cas No. |
Progesterone | CP / EP / USP / JP | CEP / EU-GMP / FDA | 57-83-0 |
Pregnenolone | In-domo |
Kosher | 145-13-1 |
Medroxyprogesterone ACETATE | CP / EP / USP / JP | Dmf / GMP | 71-58-9 |
MESTERROL acetate | CP / EP / USP | Dmf in processususus | 595-33-5 |
Mifepristone | CP / IP | Dmf / GMP | 84371-65-3 |
Cyproterone acetate | CP / EP / IP / KP | CEP / TGA / EU-GMP | 427-51-0 |
Levonorgestrel | CP / EP / USP / IP | CEP / GMP | 797-63-7 |
Norethisterone |
CP / EP / USP / JP |
Dmf in processususus |
68-22-4 |
Norethisterone acetate |
EP / USP |
Dmf in processususus |
51-98-9 |
Norethisterone Enanthate |
In-domo |
Sub R & D |
3836-23-5 |
Dripirenone | EP / USP | Dmf | 67392-87-4 |
Gestodene | CP / Album | Dmf / GMP | 60282-87-3 |
Estradiol | CP / EP / USP / KP | Dmf / GMP / WC | 35380-71-3 |
Estriol | CP / EP / USP | Sub R & D | 50-27- I |
Ethinyl estradiol | CP / EP / USP | Gmp | 57-63-6 |
Estradiol Valerate | CP / EP / USP / KP | Dmf | 979-32-8 |
Estradiol cypionate |
Usp | Dmf in processususus |
313-06-4 |
Tubolone | CP / Album | Dmf / GMP | 5630-53-5 |
Dienogest | Map | CEP / GMP | 65928-58-7 |
Fullevestrant | EP / USP | Sub R & D | 129453-61-8 |
Exemestane | CP / EP / USP | Sub R & D | 107868-30-4 |
Androgen | |||
Product Name | Specificatio | Probatus | Cas No. |
Finasteride | CP / EP / USP | CEP / FDA / PMDA / GMP | 98319-26-7 |
PRAESTITUTUM | EP / USP | CEP / FDA | 164656-23-9 |
Abiratone acetate | CP / USP | Dmf / WC | 154229-18-2 |
Darolutami |
In-domo |
Sub R & D |
1297538-32-9 |
Testosterone | CP / EP / USP | CEP / WC / FDA | 58-22-0 |
Testosterone undecanoate | CP | Dmf / WC | 5949-44-0 |
Testosterone cypionate | Usp | Sub R & D | 58-20-8 |
Testosterone enanthate |
USP / JP | Sub R & D |
315-37-7 |
Testosterone propionate |
CP / EP / USP / JP |
Sub R & D |
57-85-2 |
DHEA (in pracers) | FP /In-domo | Dmf / WC / Kosher | 53-43-0 |
Clascoterone | In-domo | Dmf in processususus | 19608-29-8 |
Cortical hormone | |||
Product Name | Specificatio | Probatus | Cas No. |
Budesonide | CP / EP / USP / JP | CEP / FDA / GMP | 51333-22-3 |
DESON | CP / USP | Dmf / GMP | 638-94-8 |
Eplerenone | Map | CEP in processusus | 107724-20-9 |
Methylprednisolone | CP / EP / USP / JP | Dmf / GMP | 83-43-2 |
Methylprednisolone Hemisuccinate | CP / EP / USP | Dmf / GMP | 2921-57-5 |
Fluticasone propionate | CP / EP / USP | Dmf | 80474- 14-2 |
Fluticasone ira | CP / Album | Dmf in processususus | 397864-44-7 |
Mometasone furoate |
CP / EP / USP |
Dmf in processususus |
Anhydrous (83919-23-7) Monohydrate (141646-00-6) |
Deflazacort |
In-domo |
Sub R & D |
14484-47-0 |
Alii | |||
Product Name | Specificatio | Probatus | Cas No. |
Oxcarbazepine | CP / EP / USP / IP | CEP / FDA / GMP | 28721-07-5 |
ESICARBAZEPAZIPAE ACETATE | CP / USP | Dmf | 236395- 14-5 |
Ganciclovir | CP / EP / USP | Dmf / GMP | 82410-32-0 |
VALCANCICLOVIR Hydrochloride | USP / Album | CEP in processus | 175865-59-5 |
Oseltamivir phosphate | CP / EP / USP | Dmf | 204255- 11-8 |
Baloxavir Marboxil | In-domo | Sub R & D | 1985606-14-1 |
Revefenacin | In-domo | Dmf | 864750-70-9 |
Mirabegron | CP / Album | Dmf | 223673-61-8 |
Vibegron |
In-domo |
Sub R & D |
1190389-15-1 |
Escitalopram oxalate | CP / EP / USP | Dmf in processusus | 219861-08-2 |
Citalopram hydrobromide |
CP / EP / USP |
Dmf in processususus |
59729-32-7 |
Cariprazine Hydrochloride | In-domo | Dmf | 1083076-69-0 |
LASMIDITAN | In-domo | Dmf | 439239-92-6 |
Luliconazole | In-domo | Dmf | 187164-19-8 |
Apalutami | In-domo | Dmf | 956104-40-8 |
Tadalafil | CP / EP / USP | Sub R & D | 171596-29-5 |
Relugolix | In-domo | Dmf in processusus | 737789-87-6 |
Phosphate Ruxolitinib |
In-domo |
Dmf in processususus |
1092939-17-7 |
Abemaciclib |
In-domo |
Sub R & D |
1231929-97-7 |
Phloroglucinol | CP / Album | Dmf | 108-73-6 |
1,3,5, trimethoxybenzene |
CP / in-Domus |
Gmp |
621-23-8 |
Ursodeoxycholic acidum | EP / USP / JP | Sub R & D | 128-13-2 |
Tauroursodeoloxycholic acidum |
In-domo |
Sub R & D |
14605-22-2 |
Cholesterol |
CP / EP / USP / JP |
Sub R & D |
57-88-5 |
Omega-III-acidum ethyl aether XC |
EP / USP |
Dmf in processususus |
- |
Medium-torquem triglycerides |
CP / USP / Album |
Dmf |
- |
Benzalkonium chloride |
USP / EP / JP |
CEP in processusus |
8001-54-5 |
Oleum (quia iniectio) |
CP / USP / EP / JP |
Dmf in processususus |
8001-25-0 |
Ovum phospholipids (quia iniectio) |
CP / USP / Album |
Dmf |
93685-90-6 |
Snack |
In-domo |
Dmf in processususus |
203787-91-1 |
Progesterone EP, USP, CP, JP, IP et KP specificationes habet.CEP in promptu sunt, EU-GMP,FDA approbavit.
Finasteride EP, USP, CP, IP, JP in promptu habet, FDA, PMDA et GMP approbavit.
Budesonide habet USP, EP specificationes. CEP, GMP et FDA probatus est.
Dutasteride EP, USP, CP, IP, JP specificationem habet. CEP et FDA praesto.
Desonide USP et EP specificationes habet. DMF praesto.
Methylprednisolone specificationes USP, EP, IP, JP, KP habet. DMF and WC available.